(Q40536084)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

S Bloom

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

S Kiilerich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M R Lassen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

K Leiper

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

E Langholz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

E J Irvine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

C O'Morain

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

D Lowson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

S Orm

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

English

0 references

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

27 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

871-878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Transdermal nicotine for active ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Elevation of hepatic transaminases after enoxaparin use: case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Prophylaxis of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01926.X

10.1111/J.1365-2036.2004.01926.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15080848%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference